These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8201630)

  • 21. Alcohol & drug abuse. HIV infection and risky sexual behaviors among women in treatment for noninjection drug dependence.
    Malow RM; Jager KB; Ireland SJ; Penedo F
    Psychiatr Serv; 1996 Nov; 47(11):1197-9. PubMed ID: 8916235
    [No Abstract]   [Full Text] [Related]  

  • 22. [Qualified inpatient acute treatment of drug dependent patients in North Rhine Westphalia].
    Kuhlmann T; Hasse HE; Sawalies D
    Psychiatr Prax; 1994 Jan; 21(1):13-8. PubMed ID: 8146239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of substance use among methadone maintenance patients. Indicators of outcome.
    Shaffer HJ; LaSalvia TA
    J Subst Abuse Treat; 1992; 9(2):143-7. PubMed ID: 1324987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a Client Problem Profile and Index for drug treatment.
    Joe GW; Simpson DD; Greener JM; Rowan-Szal GA
    Psychol Rep; 2004 Aug; 95(1):215-34. PubMed ID: 15460378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SWEDATE Project: interaction between treatment, client background, and outcome in a one-year follow-up.
    Berglund GW; Bergmark A; Björling B; Grönbladh L; Lindberg S; Oscarsson L; Olsson B; Segraeus V; Stensmo C
    J Subst Abuse Treat; 1991; 8(3):161-9. PubMed ID: 1660080
    [No Abstract]   [Full Text] [Related]  

  • 26. Motivation for treatment in a prison-based therapeutic community.
    De Leon G; Melnick G; Thomas G; Kressel D; Wexler HK
    Am J Drug Alcohol Abuse; 2000 Feb; 26(1):33-46. PubMed ID: 10718162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment process and relapse to opioid use during methadone maintenance.
    Joe GW; Simpson DD; Sells SB
    Am J Drug Alcohol Abuse; 1994; 20(2):173-97. PubMed ID: 8042602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hazelden's model of treatment and its outcome.
    Stinchfield R; Owen P
    Addict Behav; 1998; 23(5):669-83. PubMed ID: 9768302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Client matching: a severity-treatment intensity paradigm.
    De Leon G; Melnick G; Cleland CM
    J Addict Dis; 2008; 27(3):99-113. PubMed ID: 18956532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Private substance abuse treatments: are some programs more effective than others?
    McLellan AT; Grissom GR; Brill P; Durell J; Metzger DS; O'Brien CP
    J Subst Abuse Treat; 1993; 10(3):243-54. PubMed ID: 8391086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of drug dependent patients in a general hospital].
    Naber D
    Internist (Berl); 1994 Sep; 35(9):858-62. PubMed ID: 7960568
    [No Abstract]   [Full Text] [Related]  

  • 33. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the early therapeutic alliance in predicting drug treatment dropout.
    Meier PS; Donmall MC; McElduff P; Barrowclough C; Heller RF
    Drug Alcohol Depend; 2006 Jun; 83(1):57-64. PubMed ID: 16298088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of opiate users leaving detoxification treatment against medical advice.
    Kenne DR; Boros AP; Fischbein RL
    J Addict Dis; 2010 Jul; 29(3):383-94. PubMed ID: 20635287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
    Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic.
    Saxon AJ; Calsyn DA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):303-13. PubMed ID: 7484981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-reported depression as a predictor of dropout in a hierarchical therapeutic community.
    Ravndal E; Vaglum P
    J Subst Abuse Treat; 1994; 11(5):471-9. PubMed ID: 7869469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.